MiniMed Group, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Que Thanh Dallara
- Full Time Employees
- 8,000
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 18000 Devonshire Street Northridge CA United States 91325
- IPO Date
- Mar 6, 2026
- CIK
- 0002062583
- Website
- minimed.com
- Similar Companies
- Business
- MiniMed Group, Inc. (MMED) is a medical technology company focused on diabetes management solutions. The company develops, manufactures, and markets advanced insulin pumps, continuous glucose monitoring (CGM) systems, and related diabetes care products, including the MiniMed Paradigm insulin pump system; the Guardian CGM sensors and transmitters; integrated sensor-augmented pump therapy; and software platforms for data analysis and remote monitoring. It serves patients, healthcare providers, and distributors primarily in North America, Europe, and select Asia-Pacific markets. Founded in 1983 and headquartered in Northridge, California, MiniMed pioneered external insulin infusion pumps and expanded into sensor technology through key innovations in the 1990s and 2000s. In recent years, the company has pursued strategic growth, including a 2024 partnership with a leading digital health platform to enhance app-based diabetes management integration and a 2025 Series B funding round exceeding $150 million to accelerate next-generation CGM development. Additionally, MiniMed launched its MiniMed 870G system with automated insulin delivery in late 2025, marking a significant advancement in closed-loop therapy, while expanding operations into Latin America through a new distribution alliance.
Company News
How Many Shares Would It Take to Earn $1,000 a Year From This Future Dividend King?
MiniMed Announces Board of Directors for its Next Chapter as an Independent Company
MiniMed Announces Board of Directors for its Next Chapter as an Independent Company
MiniMed Completes Separation from Medtronic
Medtronic Completes Separation of MiniMed Group, Inc.
Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer
Top 10 Powder Keg Stocks Where Short Sellers Are Sitting on a Fuse
MiniMed Group (NASDAQ:MMED) Shares Gap Down – Here’s What Happened
Medtronic Announces Preliminary Results of MiniMed Group, Inc. Exchange Offer
Here Are Monday’s Top Wall Street Analyst Research Calls: Adobe, Biogen, First Solar, GoDaddy, Hubspot, Palantir Technologies, Robinhood Markets, Snowflake, TeraWulf, T-Mobile US and More
MiniMed Group Sees Unusually Large Options Volume (NASDAQ:MMED)
Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.
MiniMed Group (NASDAQ:MMED) Sees Large Volume Increase – Should You Buy?
Why I Think These Are the 2 Smartest Stocks to Buy With $5,000 in October
Responding more frequently to MiniMed Smart MDI alerts linked to better glucose outcomes for people with diabetes
Why Medtronic's $4 Billion MiniMed Exchange Offer Is Losing Its Allure
DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care
MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary
Squeeze Watch: 10 Stocks With Over 33% Short Interest
MiniMed Group, Inc. (MMED) Presents at Bank of America Global Healthcare Conference 2026 Transcript